CLL-247 Venetoclax Plus Ibrutinib As First-line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

TANRIVERDİ L. H., SARICI A.

Society of Hematologic Oncology 2024 Annual Meeting, Texas, Amerika Birleşik Devletleri, 4 - 07 Eylül 2024, cilt.24, ss.349 identifier

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 24
  • Doi Numarası: 10.1016/s2152-2650(24)01271-0
  • Basıldığı Şehir: Texas
  • Basıldığı Ülke: Amerika Birleşik Devletleri
  • Sayfa Sayıları: ss.349
  • İnönü Üniversitesi Adresli: Evet

Özet

We present new supersymmetric extensions of Conformal Toda and $A^{(1)}_N$ Affine Toda field theories. These new theories are constructed using methods similar to those that have been developed to find supersymmetric extensions of two-dimensional bosonic sigma models with a scalar potential. In particular, we show that the Conformal Toda field theory admits a (1,1)-supersymmetric extension, and the $A^{(1)}_N$ Affine Toda field admits a (1,0)-supersymmetric extension.